PITX1 as a grading, prognostic and tumor-infiltrating immune cells marker for chondrosarcoma: a public database-based immunoassay and tissue sample analysis

database[Title] 2025-05-13

Summary:

CONCLUSION: PITX1 is a novel biomarker for distinguishing between high-grade and low-grade CHS, serving as a prognostic indicator for patients with this condition and presenting a promising target for immunotherapy. These findings offer innovative insights into the treatment of CHS.

Link:

https://pubmed.ncbi.nlm.nih.gov/40342824/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12QQbiNmM99eUQGIX1JjHIKcROC1Vzv4sOS-2S_LNI19uG_Yrk&fc=20220129225649&ff=20250513213841&v=2.18.0.post9+e462414

From feeds:

📚BioDBS Bibliography » database[Title]

Authors:

Zikun Huang, Dongchen Liu, Ying Zhang, Weiqing Lu, Lan Hu, Jinghao Zhang, Lei Xie, Shubiao Chen

Date tagged:

05/13/2025, 21:38

Date published:

05/09/2025, 06:00